Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature.

Rodrigo Martino(Universitat Autònoma de Barcelona), A Domingo-Albós(Clínica Rementería), Carmen Martı́nez(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), S. Brunet(National Foundation for Cancer Research), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Rosmary López
PubMed
October 1, 1996
Cited by 49

Related Papers

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2015|740
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2022|718
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2023|538
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532